BioAffinity Technologies Names Michael Dougherty as Chief Financial Officer
BioAffinity Technologies, Inc. , a biotechnology company focused on the need for noninvasive, accurate tests for the detection of early-stage cancer, today announced that Michael Dougherty has joined... | May 1, 2023
United States Maria Zannes Michael Dougherty Michael Edwards American Institute Of Certified Public Accountants Laboratory Developed Test
Source: marketscreener.com